Testing Status of ICRF-159 C01627
CASRN: 21416-87-5
Formula: C11-H16-N4-O4
Synonyms/Common Names
- (Bis-4,4'-(1-methyl-1,2-ethanediyl)-2,6-piperazinedione
- (+-)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione
- Razoxane
Short-Term Toxicity
- 14-Day (Intraperitoneal Injection)
(C01627)
Completed
- Rats: Sprague Dawley; Mice: B6C3F1
- 13-Week (Intraperitoneal Injection)
(C01627)
Completed
- Rats: Sprague Dawley; Mice: B6C3F1
- Dose: FR: 0, 1.2, 384, MM: 0, 2, 640 MG/KG/5 PER GROUP.
Long-Term Carcinogenicity
- 2-Year (Intraperitoneal Injection)
(C01627)
Completed
- TR-078 (NIH Number: 78-1328)
(Peer Review Approval 03/07/1978A )
Bioassay of ICRF-159 for Possible Carcinogenicity (CASRN 21416-87-5) - Rats: Sprague Dawley; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Negative
- Female Rats Positive
- Male Mice Negative
- Female Mice Positive
- Dose: R: 0, 48, 96, M: 0, 40, 80 MG/KG/35 PER GROUP.
- TR-078 (NIH Number: 78-1328)
(Peer Review Approval 03/07/1978A )